Related Experiment Video
Updated: May 5, 2026

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
Published on: April 9, 2019
Brain and Spinal Leptomeningeal Metastases in Prostate Cancer Detected by PSMA PET and MRI Fusion
1Department of Radiology, Division of Nuclear Medicine, Temple University Health System, Fox Chase Cancer Center, Philadelphia, PA.
Abstract:
A 66-year-old man with metastatic castration-resistant prostate adenocarcinoma experienced a rising PSA after multiple systemic therapies and radiation therapy to the cervical and thoracic spine for bone metastases. F-18 piflufolastat (Pylarify) PSMA PET/CT demonstrated widespread metastases, involving bones, lungs, mediastinal and hilar lymph nodes, liver, and intracranial and intraspinal sites. He subsequently developed worsening neurological symptoms. Brain MRI fused with PSMA PET revealed numerous radiotracer-avid scattered leptomeningeal enhancing foci intracranially. Cervical spine MRI fused with PSMA PET demonstrated multifocal radiotracer-avid intradural, extramedullary enhancing lesions. Biopsy of cervical intradural lesions confirmed metastatic prostate carcinoma.

